Introduction: atherosclerosis as inflammation: a controversial concept becomes accepted.
Hansson
G K
GK
Center for Molecular Medicine, Department of Medicine, Karolinska Institute, Stockholm, Sweden. jan.nilsson@med.lu.se
Nilsson
J
J
D000818:Animals; D050197:Atherosclerosis / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology; D052246:Cyclooxygenase 2 Inhibitors / Q000627:therapeutic use; D004195:Disease Models, Animal; D006801:Humans; D018836:Inflammation Mediators / Q000627:therapeutic use; D051379:Mice; D018417:Th1 Cells / Q000378:metabolism; D013927:Thrombosis / Q000188:drug therapy / Q000276:immunology; D014657:Vasculitis / Q000209:etiology* / Q000276:immunology
D052246:Cyclooxygenase 2 Inhibitors; D018836:Inflammation Mediators